AMAL Therapeutics

Showing 2 posts of 2 posts found.


Top Ten most popular articles on this week!

July 19, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMAL Therapeutics, Alzheimer's Ebola, Amgen, AstraZeneca, EMA, FDA, Novartis, pharma

On 12 July news broke that Novartis, Amgen and Banner’s Alzheimer’s Institute were discontinuing a trial into investigational compound CNP520 …


Boehringer buys cancer vaccine company AMAL Therapeutics for €325 million

July 16, 2019
Manufacturing and Production AMAL Therapeutics, Boehringer Ingelheim, Geneva, cancer vaccines, oncology

Boehringer Ingelheim has bought Swiss biotech AMAL Therapeutics, a company focused on cancer immunotherapy and cancer vaccines. AMAL’s lead candidate, …

Latest content